Chairman and CEO of the company Parker Petit said the company has been successful in reducing its adjusted EBITDA loss in the third quarter by almost $500,000 as compared to the second quarter of 2011 as well as improved sales in the wound care and spine markets. During this quarter, the company initiated its AmnioFix and EpiFix allografts.
Related Articles on Orthopedic Device Companies:
Arthrosurface Launches First Ankle Resurfacing System
Wright Medical Group Names Julie Tracy Senior Vice President, Chief Communications Officer
More Insurance Companies Now Reimburse for TranS1’s AxiaLIF
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
